Institutional Investors Increase Holdings in Hanwha Vision, Millie's Library, InnoX Advanced Materials, and More

Reporter Paul Lee / approved : 2025-02-14 01:49:37
  • -
  • +
  • 인쇄

Image Credit: Korea Exchange

 

 

[Alpha Biz= Paul Lee] This week, institutional investors have increased their stakes in companies such as Hanwha Vision, Millie's Library, InnoX Advanced Materials, DB HiTek, and HVEM.


According to Thinkpool on Thursday, institutional investors bought a total of 1,486,492 shares of Hanwha Vision between the 7th and 12th of February. This amount represents 2.9% of the company's total shares. Hanwha Vision was recently absorbed by Hanwha Industrial Solutions.


Institutional investors also increased their holdings in APR. During the same week, they bought 565,977 shares of APR, which is 1.5% of the company's total shares. Additionally, institutional investors purchased 767,303 shares of Isu Petasis.


Foreign investors have also significantly increased their stakes in SAMG Entertainment, LS Materials, Filoptics, Next Biomedical, and Quantamatrix. LS Materials, a company involved in manufacturing next-generation ultra-capacitors for secondary batteries, saw foreign investors purchase 2,256,683 shares, which is 3.3% of the company's total shares.


Foreign investors also bought 379,329 shares of SAMG Entertainment, increasing their holding by 4.4%. The news of Samsung Electronics entering the glass substrate business sparked expectations that Filoptics would benefit from this development, leading foreign investors to purchase 696,102 shares, or 3% of the company's total shares.


Sands Lab has been in the news recently due to the controversy over personal data leaks of China's AI "DeepSeek." Foreign investors bought 381,877 shares of Sands Lab.


In addition, foreign investors bought 223,569 shares of Next Biomedical, which specializes in innovative medical materials, representing 2.8% of the company's total shares. They also purchased 434,966 shares of Quantamatrix, a company involved in research, development, production, and sales of in-vitro diagnostic medical devices, expanding their holding in the company.

 

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

주요기사

Korea’s Top Trade Negotiator Heads to Washington as U.S.-Korea Tariff Talks Stall, Japan Wins Tariff Reduction2025.09.16
Samsung Releases First Official Photo of Chairman Lee Jae-yong’s Son as He Enters Naval Officer Training2025.09.16
Security Firm Reported LG Uplus Hacking Incident Despite Telecoms’ Denial2025.09.16
HYBE Chairman Bang Si-hyuk Questioned by Police Over Alleged KRW 190 Billion IPO Fraud2025.09.16
Homeplus Union Suspends Sit-In Protest After Five Months Following Government Pledge2025.09.16
뉴스댓글 >